sb 203580 has been researched along with prednisolone in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (prednisolone) | Trials (prednisolone) | Recent Studies (post-2010) (prednisolone) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 34,414 | 3,302 | 7,141 |
| Protein | Taxonomy | sb 203580 (IC50) | prednisolone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.0278 | |
| Progesterone receptor | Homo sapiens (human) | 2.08 | |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | 0.0565 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.016 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0322 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.016 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.016 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.016 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henne, WA; Kularatne, SA; Low, PS; Santhapuram, HK; Vaitilingam, B; Venkatesh, C; Wang, K | 1 |
| Beal, AM; Berger, SB; Bertin, J; Bury, MJ; Capriotti, CA; Casillas, LN; Charnley, AK; Convery, MA; Cook, MN; Cucchiara, S; Desai, BM; Finger, JN; Gough, PJ; Haile, PA; King, BW; Lakdawala, AS; Lipshutz, DB; MacDonald, TT; Mahajan, MK; Marquis, RW; Mehlmann, JF; Nagilla, R; Negroni, A; Ouellette, MT; Pierdomenico, M; Reilly, MA; Rivera, EJ; Singhaus, R; Stronati, L; Sun, HH; Swift, B; Totoritis, RD; Vossenkämper, A; Votta, BJ; Ziółkowski, B | 1 |
2 other study(ies) available for sb 203580 and prednisolone
| Article | Year |
|---|---|
Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs.
Topics: Antigens, Surface; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Glutamate Carboxypeptidase II; Glutarates; Humans; Ligands; Male; Molecular Targeted Therapy; Prodrugs; Prostatic Neoplasms; Structure-Activity Relationship; Urea | 2010 |
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase.
Topics: Aminoquinolines; Animals; Dose-Response Relationship, Drug; Female; Humans; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptor-Interacting Protein Serine-Threonine Kinase 2; Structure-Activity Relationship; Sulfones | 2016 |